Good evening :)
$
₹
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share

Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share

OACC

NASDAQ
Asset Logo

Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share

OACC

NASDAQ
$10.700.13% (-0.01)
$
₹
$10.700.13% (-0.01)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Unknown

Sector and industry information not available

Micro Cap

With a market cap of $263.0M the stock is ranked 3938

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

—
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

0
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

—
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

—
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

0%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Company Profile

Company Profile

Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.

Peers

Compare with peers Compare with peers 

Peers

Compare with peers Compare with peers 
McKesson Corporation
MCK
McKesson Corporation
P/E Ratio
27.58
27.58
1Y Return
26.97%
26.97%
Buy Reco %
81.25
81.25
Cencora Inc.
COR
Cencora Inc.
P/E Ratio
25.28
25.28
1Y Return
0.16%
0.16%
Buy Reco %
71.42
71.42
Cardinal Health Inc
CAH
Cardinal Health Inc
P/E Ratio
34.97
34.97
1Y Return
33.1%
33.1%
Buy Reco %
82.35
82.35
Henry Schein Inc
HSIC
Henry Schein Inc
P/E Ratio
24.17
24.17
1Y Return
22.53%
22.53%
Buy Reco %
50.00
50.00
Adapthealth Corp
AHCO
Adapthealth Corp
P/E Ratio
—
—
1Y Return
29.3%
29.3%
Buy Reco %
100.00
100.00
Compare with Peers

Financials

Financials

Income

Balance Sheet

Cash Flow

Hmm, looks like data is currently unavailable. Once it's updated, you can view it here

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from

Valuation

Returns

Forecast

ScreenerCompare valuation on Screener
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share -0-
McKesson Corporation27.585.041.87
Cencora Inc.25.2821.290.71
ScreenerCompare valuation on Screener

Price Comparison

Price Comparison

Compare OACC with any stock or ETF
Compare OACC with any stock or ETF
Comparing from
OACC
MCK
COR
Loading...

Frequently asked questions

  1. Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC) share price today is $10.70 as of November 5, 2026 at 11:37 PM IST. The stock touched a day high of $10.75 and a day low of $10.68.

  2. Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share stock trades on NASDAQ under the ticker symbol OACC.

  3. Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share's market capitalization is $263.03M as of November 5, 2026 at 11:37 PM IST.

  4. Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share's price-to-earnings (P/E) ratio is N/A as of November 5, 2026.

  5. Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share's price-to-book (P/B) ratio is 0 as of November 5, 2026.

  6. Yes, You can buy Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share shares in three steps: 1. Search Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.9341 shares at the current price of $10.70.

Loading...